Abstract | BACKGROUND: OBJECTIVE: METHODS: A randomized (2:1 retapamulin to sodium fusidate), observer-blinded, noninferiority, phase III study in 519 adult and pediatric (aged > or = 9 months) subjects. RESULTS:
Retapamulin and sodium fusidate had comparable clinical efficacies (per-protocol population: 99.1 and 94.0%, respectively; difference: 5.1%, 95% confidence interval: 1.1-9.0%, p = 0.003; intent-to-treat population: 94.8 and 90.1%, respectively; difference: 4.7%, 95% confidence interval: -0.4 to 9.7%, p = 0.062). Bacteriological efficacies were similar. Success rates in the small numbers of sodium-fusidate-, methicillin- and mupirocin-resistant Staphylococcus aureus were good for retapamulin (9/9, 8/8 and 6/6, respectively). Both drugs were well tolerated. CONCLUSION:
Retapamulin is a highly effective and convenient new treatment option for impetigo, with efficacy against isolates resistant to existing therapies.
|
Authors | Arnold P Oranje, Olivier Chosidow, Sarvajnamurthy Sacchidanand, Gail Todd, Krishan Singh, Nicole Scangarella, Ribhi Shawar, Monique Twynholm, TOC100224 Study Team |
Journal | Dermatology (Basel, Switzerland)
(Dermatology)
Vol. 215
Issue 4
Pg. 331-40
( 2007)
ISSN: 1421-9832 [Electronic] Switzerland |
PMID | 17911992
(Publication Type: Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | 2007 S. Karger AG, Basel |
Chemical References |
- Anti-Bacterial Agents
- Bridged Bicyclo Compounds, Heterocyclic
- Diterpenes
- Ointments
- retapamulin
- Fusidic Acid
|
Topics |
- Administration, Topical
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anti-Bacterial Agents
(administration & dosage)
- Bridged Bicyclo Compounds, Heterocyclic
(administration & dosage)
- Child
- Child, Preschool
- Diterpenes
- Dose-Response Relationship, Drug
- Female
- Follow-Up Studies
- Fusidic Acid
(administration & dosage)
- Humans
- Impetigo
(drug therapy, microbiology, pathology)
- Infant
- Infant, Newborn
- Male
- Middle Aged
- Ointments
- Single-Blind Method
- Skin
(microbiology, pathology)
- Staphylococcus aureus
(isolation & purification)
- Streptococcus pyogenes
(isolation & purification)
- Treatment Outcome
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|